Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

A simple method for displaying the hydropathic character of a protein

Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,694 · see citing works

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · see citing works

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

Empirical Predictions of Protein Conformation

Chou, P. Y., & Fasman, G. D. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.001343 · Cited by 3,137 · see citing works

Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302 · see citing works

A gas-liquid solid phase peptide and protein sequenator.

Hewick, R. M., Hunkapiller, M. W., Hood, L., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218 · see citing works

Calcitonin gene-related peptide is a potent vasodilator

Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R., & MacIntyre, I. M. (1985) · Nature · doi:10.1038/313054a0 · Cited by 2,086 · see citing works

Atlas of Protein Sequence and Structure, 1966.

Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,808 · see citing works

Amino acid analysis by reverse-phase high-performance liquid chromatography: Precolumn derivatization with phenylisothiocyanate

Heinrikson, R. L., & Meredith, S. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90307-5 · Cited by 1,634 · see citing works

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,334 · see citing works

[47] Establishing homologies in protein sequences

Dayhoff, M. O., Barker, W. C., & Hunt, L. T. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(83)91049-2 · Cited by 1,169 · see citing works

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976 · see citing works

The characterization of soluble amyloid prepared in water

Pras, M., Zucker‐Franklin, D., Rimon, A., & Franklin, E. C. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105784 · Cited by 643 · see citing works

Calcitonin gene-related peptide: functional role in cerebrovascular regulation.

McCulloch, J., Uddman, R., Kingman, T. A., & Edvinsson, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5731 · Cited by 514 · see citing works

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas

Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512 · see citing works

Isolation and characterization of human calcitonin gene-related peptide

Morris, H. R., Panico, M., Etienne, T., Tippins, J. R., Girgis, S. I., & MacIntyre, I. M. (1984) · Nature · doi:10.1038/308746a0 · Cited by 423 · see citing works

Insulin deficiency and insulin resistance interaction in diabetes: Estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations

Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388 · see citing works

A second human calcitonin/CGRP gene

Steenbergh, P. H., Höppener, J. W. M., Zandberg, J., Lips, C. J. M., & Jansz, H. S. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80820-6 · Cited by 364 · see citing works

The current status and portability of our sequence handling software

Staden, R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.1.217 · Cited by 354 · see citing works

ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES

Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350 · see citing works

Calcitonin gene-related peptide in cardiovascular tissues of the rat

Mulderry, P. K., Ghatei, M. A., Rodrigo, J., Allen, J. M., Rosenfeld, M. G., Polak, J. M., & Bloom, S. R. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90156-3 · Cited by 334 · see citing works

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

Westermark, P., & Wilander, E. (1978) · Diabetologia · doi:10.1007/bf01219652 · Cited by 291 · see citing works

Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone.

Westermark, P., Wernstedt, C., O’Brien, T. D., Hayden, D. W., & Johnson, K. H. (1987) · PubMed Central · Cited by 261 · see citing works

BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES

O’Rahilly, S., Rudenski, A. S., Burnett, M. A., Nugent, Z. J., Hosker, J. P., Darling, P., & Turner, R. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90052-8 · Cited by 229 · see citing works

Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals.

Ehrlich, J. C., & Ratner, I. M. (1961) · PubMed · Cited by 176 · see citing works

Calcitonin Gene-Related Peptide: Occurrence in Pancreatic Islets in the Mouse and the Rat and Inhibition of Insulin Secretion in the Mouse*

Pettersson, M., Åhrén, B., Böttcher, G., & Sundler, F. (1986) · Endocrinology · doi:10.1210/endo-119-2-865 · Cited by 152 · see citing works

INSULIN RESPONSE TO GLUCOSE INFUSION IN DIABETIC AND NON-DIABETIC MONOZYGOTIC TWIN PAIRS. GENETIC CONTROL OF INSULIN RESPONSE?

Cerasi, E., & Luft, R. (1967) · European Journal of Endocrinology · doi:10.1530/acta.0.0550330 · Cited by 148 · see citing works

Fine structure of islets of Langerhans in insular amyloidosis

Westermark, P. (1973) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00549079 · Cited by 147 · see citing works

Longitudinal studies on the development of diabetes in individual Macaca nigra

Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141 · see citing works

An empirical demonstration of Berkson's bias

Roberts, R. S., Spitzer, W. O., Delmore, T., & Sackett, D. L. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90097-8 · Cited by 133 · see citing works

The relation of islet amyloid to the clinical type of diabetes

Maloy, A. L., Longnecker, D. S., & Greenberg, E. R. (1981) · Human Pathology · doi:10.1016/s0046-8177(81)80197-9 · Cited by 129 · see citing works

Hyalinization of the islets of Langerhans in nondiabetic individuals.

BELL, E. T. (2000) · PubMed · Cited by 107 · see citing works

Hyalinization of the Islets of Langerhans in Diabetes Mellitus

Bell, E. T. (1952) · Diabetes · doi:10.2337/diab.1.5.341 · Cited by 84 · see citing works

Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin

Westermark, P., & Wilander, E. (1983) · Diabetologia · doi:10.1007/bf00251821 · Cited by 62 · see citing works

Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes mellitus* 1

Schneider, H.-M., Störkel, S., & Will, W. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1070828 · Cited by 57 · see citing works

Light and Electron Microscopic Studies of Islet Amyloid in Diabetic Cats

Johnson, K. H., & Stevens, J. B. (1973) · Diabetes · doi:10.2337/diab.22.2.81 · Cited by 47 · see citing works

CALCITONIN GENE‐RELATED PEPTIDE AND CALCITONIN IN MEDULLARY THYROID CARCINOMA

Schifter, S., Williams, E. D., CRAIG, R. K., & Hansen, H. H. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03626.x · Cited by 42 · see citing works

The Nature of the Hyaline Material in the Pancreatic Islands in Diabetes Mellitus.

Jh, A. (1943) · PubMed · Cited by 35 · see citing works

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · see citing works

Inflammasomes: mechanism of action, role in disease, and therapeutics

Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · see citing works

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes

Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · see citing works

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417 · see citing works

Intrinsically Disordered Proteins in Human Diseases: Introducing the D 2 Concept

Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,406 · see citing works

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360 · see citing works

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · see citing works

Calcitonin Gene-Related Peptide: Physiology and Pathophysiology

Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,278 · see citing works

Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes

Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177 · see citing works

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,128 · see citing works

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus

Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044 · see citing works

Conformational constraints for amyloid fibrillation: the importance of being unfolded

Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,012 · see citing works

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935 · see citing works

Cognitive Dysfunction and Diabetes Mellitus

Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 823 · see citing works

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

Lorenzo, A., Razzaboni, B. L., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 819 · see citing works

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807 · see citing works

International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · see citing works

Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin

Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765 · see citing works

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 694 · see citing works

Endoplasmic Reticulum Stress and Type 2 Diabetes

Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 621 · see citing works

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612 · see citing works

Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes

Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 586 · see citing works

Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR

Luca, S., Yau, W., Leapman, R. D., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 579 · see citing works

Glucose Metabolism and Regulation: Beyond Insulin and Glucagon

Aronoff, S. L., Berkowitz, K. J., Schreiner, B., & Want, L. L. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.3.183 · Cited by 567 · see citing works

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562 · see citing works

Molecular dynamics simulations and novel drug discovery

Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1403419 · Cited by 520 · see citing works

Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors

van Rossum, D., Hanisch, U., & Quirion, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00023-1 · Cited by 512 · see citing works

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro

Leighton, B., & Cooper, G. J. S. (1988) · Nature · doi:10.1038/335632a0 · Cited by 473 · see citing works

Pathogenesis of Type 2 Diabetes Mellitus

Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469 · see citing works

Small Bioactive Peptides for Biomaterials Design and Therapeutics

Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461 · see citing works

Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells

Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454 · see citing works

Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin

Mirzabekov, T. A., Lin, M., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442 · see citing works

Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties

Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M. M., Weber, M., Merkle, M., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 428 · see citing works

Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide

Rosenfeld, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 421 · see citing works

The New Biology and Pharmacology of Glucagon

Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419 · see citing works

Amylin: Pharmacology, Physiology, and Clinical Potential

Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400 · see citing works

Amyloid peptides are toxic via a common oxidative mechanism.

Schubert, D. A., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., & Kimura, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1989 · Cited by 379 · see citing works

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371 · see citing works

Common pathological processes in Alzheimer disease and type 2 diabetes: A review

Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367 · see citing works

Islet inflammation in type 2 diabetes and physiology

Eguchi, K., & Nagai, R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88877 · Cited by 361 · see citing works

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.

Cooper, G. J. S., Leighton, B., Dimitriadis, G., Parry‐Billings, M., Kowalchuk, J. M., Howland, K., Rothbard, J. B., Willis, A. C., & Reid, K. B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7763 · Cited by 348 · see citing works

Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in Vitro

Kayed, R., Bernhagen, J., Greenfield, N. J., Sweimeh, K., Brunner, H., Voelter, W., & Kapurniotu, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2646 · Cited by 351 · see citing works

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

Zhao, W., & Townsend, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.014 · Cited by 353 · see citing works

β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition

Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329 · see citing works

Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans

Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330 · see citing works

Watching amyloid fibrils grow by time-lapse atomic force microscopy 1 1Edited by W. Baumeister

Goldsbury, C. S., Kistler, J., Aebi, U., Arvinte, T., & Cooper, G. J. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2299 · Cited by 324 · see citing works

Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin)

Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., Cascio, D., Popov, D., Riekel, C., & Eisenberg, D. S. (2008) · Protein Science · doi:10.1110/ps.036509.108 · Cited by 320 · see citing works

Amyloid Fibril Formation from Full-Length and Fragments of Amylin

Goldsbury, C. S., Goldie, K. N., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316 · see citing works

Protein folding revisited. A polypeptide chain at the folding ? misfolding ? nonfolding cross-roads: which way to go?

Uversky, V. N. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3096-6 · Cited by 314 · see citing works

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288 · see citing works

Islet β cell mass in diabetes and how it relates to function, birth, and death

Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296 · see citing works

Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins

Munishkina, L. A., & Fink, A. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.015 · Cited by 295 · see citing works

Polymorphic Fibrillar Assembly of Human Amylin

Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Müller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A. H., Aebi, U., & Kistler, J. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3858 · Cited by 293 · see citing works

Focus on the Role of NLRP3 Inflammasome in Diseases

Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Paola, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 292 · see citing works

Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution

Shim, S., Gupta, R., Ling, Y. L., Strasfeld, D. B., Raleigh, D. P., & Zanni, M. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805957106 · Cited by 286 · see citing works

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278 · see citing works

The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity

Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282 · see citing works

In vitro autoradiographic localization of amylin binding sites in rat brain

Sexton, P. M., Paxinos, G., Kenney, M. A., Wookey, P. J., & Beaumont, K. C. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90388-3 · Cited by 277 · see citing works

The Impact of Disease Comorbidities in Alzheimer’s Disease

Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259 · see citing works

Islet amyloid polypeptide: structure, function, and pathophysiology

Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273 · see citing works

An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.

Sanke, T., Bell, G. I., Sample, C. E., Rubenstein, A. H., & Steiner, D. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77825-9 · Cited by 258 · see citing works

The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus

Kahn, S. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00336-3 · Cited by 242 · see citing works

Amylin Agonists: A Novel Approach in the Treatment of Diabetes

Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 237 · see citing works

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Judith Miklossy, A., Qing, H., Rađenović, A., Kis, A., Vileno, B., Laszlo Forro, C., Miller, L. M., Martins, R. N., Waeber, G., Mooser, V., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.019 · Cited by 237 · see citing works

The road to the synthesis of “difficult peptides”

Paradís‐Bas, M., Tulla‐Puche, J., & Alberício, F. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00680e · Cited by 237 · see citing works

Recent Insights in Islet Amyloid Polypeptide‐Induced Membrane Disruption and Its Role in β‐Cell Death in Type 2 Diabetes Mellitus

Khemtémourian, L., Killian, J. A., Höppener, J. W. M., & Engel, M. F. M. (2008) · Journal of Diabetes Research · doi:10.1155/2008/421287 · Cited by 236 · see citing works

The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting.

Pedersen, J., Dikov, D., Flink, J., Hjuler, H., Christiansen, G., & Otzen, D. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.100 · Cited by 235 · see citing works

Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans

Karhunen, L. J., Juvonen, K. R., Huotari, A., Purhonen, A., & Herzig, K. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.10.008 · Cited by 233 · see citing works

Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases

Carniglia, L., Ramírez, D., Durand, D., Saba, J., Turati, J., Caruso, C. M., Scimonelli, T. N., & Lasaga, M. (2017) · Mediators of Inflammation · doi:10.1155/2017/5048616 · Cited by 231 · see citing works

The role of FOXO1 in β-cell failure and type 2 diabetes mellitus

Kitamura, T. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.157 · Cited by 222 · see citing works

Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure

Tyndall, J. D. A., Pfeiffer, B., Abbenante, G., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040689g · Cited by 220 · see citing works

Adiposity signals and the control of energy homeostasis

Woods, S. C., & Seeley, R. J. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00454-8 · Cited by 221 · see citing works

The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells

Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219 · see citing works

Transcriptomes of the major human pancreatic cell types

Dorrell, C., Schug, J., Lin, C., Canaday, P. S., Fox, A. J., Smirnova, O., Bonnah, R. A., Streeter, P. R., Stoeckert, C. J., Kaestner, K. H., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2283-5 · Cited by 218 · see citing works

Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis

Zraika, S., Hull, R. L., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 215 · see citing works

Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation

Honda, H., Nagai, Y., Matsunaga, T., Okamoto, N., Watanabe, Y., Tsuneyama, K., Hayashi, H., Fujii, I., Ikutani, M., Hirai, Y., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-005rr · Cited by 213 · see citing works

Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process

Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., & Eisenberg, D. S. (2009) · Protein Science · doi:10.1002/pro.145 · Cited by 208 · see citing works

Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

Epstein, F. H., Johnson, K. H., O'Brien, T. D., Betsholtz, C., & Westermark, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210806 · Cited by 205 · see citing works

Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment.

Ogawa, A., Harris, V., McCorkle, S. K., Unger, R. H., & Luskey, K. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114528 · Cited by 205 · see citing works

Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202 · see citing works

Apoptosis in pancreatic β-islet cells in Type 2 diabetes

Tomita, T. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.919 · Cited by 197 · see citing works

Molecular links between Alzheimer’s disease and diabetes mellitus

Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 202 · see citing works

Mechanisms of islet amyloidosis toxicity in type 2 diabetes

Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 201 · see citing works

Islet amyloid polypeptide and type 2 diabetes.

Marzban, L., Park, K., & Verchere, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00004-4 · Cited by 191 · see citing works

Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes

Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 199 · see citing works

Anti-obesity therapy: from rainbow pills to polyagonists

Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199 · see citing works

Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets

Ritzel, R. A., Meier, J. J., Lin, C., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db06-0734 · Cited by 193 · see citing works

The insulin secretory granule

Hutton, J. C. (1989) · Diabetologia · doi:10.1007/bf00265542 · Cited by 192 · see citing works

Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.

Wang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., Jr., & FEUERSTEIN, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · see citing works

Ion Mobility Spectrometry–Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors

Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190 · see citing works

Amyloidogenesis of Natively Unfolded Proteins

Uversky, V. N. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533312 · Cited by 187 · see citing works

Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes

Moreira, P. I., Santos, M. S., Seiça, R. M. F., & Oliveira, C. R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.017 · Cited by 190 · see citing works

The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism

Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182 · see citing works

Helix Stabilization Precedes Aqueous and Bilayer-Catalyzed Fiber Formation in Islet Amyloid Polypeptide

Williamson, J. A., Loria, J. P., & Miranker, A. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.077 · Cited by 186 · see citing works

Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction?

Porte, D., & Kahn, S. E. (1989) · Diabetes · doi:10.2337/diab.38.11.1333 · Cited by 185 · see citing works

Induction of Insulin Resistance In Vivo by Amylin and Calcitonin Gene–Related Peptide

Molina, J. M., Cooper, G. J. S., Leighton, B., & Olefsky, J. M. (1990) · Diabetes · doi:10.2337/diab.39.2.260 · Cited by 184 · see citing works

Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced β-Cell Apoptosis in h-IAPP Transgenic Mice

Lin, C., Gurlo, T., Kayed, R., Butler, A. E., Haataja, L., Glabe, C. G., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db06-1579 · Cited by 182 · see citing works

Effects of in vivo conditions on amyloid aggregation

Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 179 · see citing works

ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES

Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350 · see citing works

Pancreatic Islet Amyloid and Diabetes

Clark, A., & Moffitt, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_10 · Cited by 7 · see citing works

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas

Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512 · see citing works

Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets

Ohsawa, H., Kanatsuka, A., Yamaguchi, T., Makino, H., & Yoshida, S. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92529-1 · Cited by 186 · see citing works

Antibodies specific for the pancreatic islet amyloid polypeptide associated with Type 2 diabetes mellitus

Glenner, G. G., Ceja, F., & Mehlhaff, P. M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90005-3 · Cited by 5 · see citing works